BackCassava Sciences- Warrants (15/11/2024) Overview

Cassava Sciences- Warrants (15/11/2024) Receivables

Cassava Sciences- Warrants (15/11/2024)'s receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-864000.00 vs prior year quarter

Peer average

Loading

Cassava Sciences- Warrants (15/11/2024) Receivables History

Loading

Cassava Sciences- Warrants (15/11/2024) vs. peers: Receivables Comparison

Loading

Cassava Sciences- Warrants (15/11/2024) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cassava Sciences- Warrants (15/11/2024) (SAVAW) FAQ

As of the most recent data (March 2026), SAVAW shows a receivables of $0. That compares with $860K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAVAW's receivables is now $0 (was $860K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cassava Sciences- Warrants (15/11/2024) is outperforming or lagging.

Tracking SAVAW's receivables over time shows whether Cassava Sciences- Warrants (15/11/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $860K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cassava Sciences- Warrants (15/11/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Cassava Sciences- Warrants (15/11/2024)'s receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.